FIBRONECTIN PREVENTS D-galactosamine/Lipopolysaccharide-induced lethal hepatic failure in mice
Authors:
- A-Hon KwonAKA-Hon Kwon
- Katsushige TsujiKTKatsushige Tsuji
- Yasuo KamiyamaYKYasuo Kamiyama
- Tadayoshi OkumuraTOTadayoshi Okumura
- Yutaka HiraoYHYutaka Hirao
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 25 (1) , 80-87
Abstract
Plasma fibronectin (FN) has a broad range of biological functions involved in cellular adhesion, motility, differentiation, apoptosis, hemostasis, wound healing, reticuloendothelial system function, and ischemic injury. In this study, we examined the effects of FN on D-galactosamine (GalN)/lipopolysaccharide (LPS)-induced fulminant liver failure in mice. Female Balb/c mice received intraperitoneal injection of 50 μg/kg of LPS and 400 mg/kg of GalN simultaneously. Thirty minutes before GalN/LPS administration, human plasma FN (FN group) or the same dose of human serum albumin (control group) was given intravenously. GalN/LPS induced a marked decrease in plasma FN, which was reversed by FN pretreatment. The survival rate of the FN group was markedly improved in a dose-dependent manner compared with that of the control group (survival rate 0%). FN prevented increases in the concentrations of serum enzymes and total bilirubin related to liver injury. FN pretreatment significantly suppressed tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and interleukin (IL)-6 levels, and enhanced IL-10 levels in serum and liver tissue compared with the control group. Moreover, TUNEL staining, caspase 3 and 8 activities, and necrosis in the remnant liver were significantly decreased in the FN-treated rats compared with the controls. Furthermore, FN pretreatment inhibited the activation of nuclear factor (NF)-κB and increased the expression of Bcl-xL protein in liver tissue. These results suggest that FN protected against GalN/LPS-induced liver failure by a mechanism involving inhibition of NF-κB activation, which caused down-regulation of TNF-α and involved up-regulation of IL-10, and elevation of Bcl-xL induced a blockage of apoptotic signals, by which apoptosis of hepatocytes caused by GalN/LPS was suppressed.Keywords
This publication has 28 references indexed in Scilit:
- Fibronectin, integrins, and growth controlJournal of Cellular Physiology, 2001
- Mutations in the Heparin Binding Domain of Fibronectin in Cooperation with the V Region Induce Decreases in pp125 Levels Plus Proteoglycan-mediated Apoptosis via CaspasesJournal of Biological Chemistry, 1999
- Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma CellsJournal of Biological Chemistry, 1998
- Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized miceGastroenterology, 1996
- Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortalityJournal of Hepatology, 1995
- Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challengeJournal of Hepatology, 1995
- Response of Fibronectin to Liver Regeneration After HepatectomyHepatology, 1990
- Fibronectin and Kupffer cell function in fulminant hepatic failureDigestive Diseases and Sciences, 1985
- Fibronectin in fulminant hepatic failure.BMJ, 1982
- Response of Plasma Fibronectin to Major Body Burn1980